December 2013
October 2013
August 2013
June 2013
April 2013
February 2013Sign Up for Free e-newsletters
ONA Articles
- Aggressive EOL Care Negatively Impacts Care Quality, Health Costs in Metastatic Lung Cancer
- Navigation at the End of Therapy: A Crucial Transition in Lymphoma Treatment
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Managing Dermatologic Adverse Events in Patients Receiving Third-Generation EGFR-TKIs
- Risk of Relapse Up for Young Adults With Leukemia
- Tandem Autologous-Allogenic HCT Offers Long-Term Remission in Multiple Myeloma
- Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
- Tool Addresses Well-being of Informal Caregivers of Patients With Cancer
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- NHS, HPFS Show Regular Aspirin Use Reduced Hepatocellular Carcinoma Risk
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Myelofibrosis: From Diagnosis to Early Intervention
- FDA Approves HPV Vaccine for People Through Age 45
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |